| Robert Gregory Splawn, MD | |
|
19191 S Vermont Ave, Torrance, CA 90502-1018 | |
| (310) 354-4340 | |
| Not Available |
| Full Name | Robert Gregory Splawn |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 19191 S Vermont Ave, Torrance, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336165042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A045945 (California) | Primary |
| Entity Name | Concentra Primary Care Of California A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912472531 PECOS PAC ID: 4486995461 Enrollment ID: O20190402000692 |
News Archive
The researchers analysed the impact of both fat (lipid) and vitamin C (ascorbic acid) on nitrite chemistry in the upper (proximal) stomach, which is especially vulnerable to pre-cancerous changes and tumour growth.
International animal and human health experts today unveiled a multi-point plan designed to reduce the risk of the H5N1 avian influenza virus spreading from poultry to humans, and appealed to the international community to come forward with funds to make it work and help stave off the risk of an influenza pandemic.
Today's decision by the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the reclassification of azithromycin for the treatment of chlamydia infection will mean convenient and effective care for patients, said the Royal Pharmaceutical Society of Great Britain (RPSGB).
The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful. However, reducing the number of potentially inappropriate medications that seniors take on a daily basis is an ongoing challenge.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Gregory Splawn, MD 1133 N Formosa Ave Apt 3, West Hollywood, CA 90046-5857 Ph: (323) 876-0229 | Robert Gregory Splawn, MD 19191 S Vermont Ave, Torrance, CA 90502-1018 Ph: (310) 354-4340 |
News Archive
The researchers analysed the impact of both fat (lipid) and vitamin C (ascorbic acid) on nitrite chemistry in the upper (proximal) stomach, which is especially vulnerable to pre-cancerous changes and tumour growth.
International animal and human health experts today unveiled a multi-point plan designed to reduce the risk of the H5N1 avian influenza virus spreading from poultry to humans, and appealed to the international community to come forward with funds to make it work and help stave off the risk of an influenza pandemic.
Today's decision by the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the reclassification of azithromycin for the treatment of chlamydia infection will mean convenient and effective care for patients, said the Royal Pharmaceutical Society of Great Britain (RPSGB).
The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful. However, reducing the number of potentially inappropriate medications that seniors take on a daily basis is an ongoing challenge.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
› Verified 4 days ago
Dr. Gina L Sulmeyer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-517-4785 | |
Dr. Manpreet Singh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Ryan Gleber, MD, BS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-325-9110 | |
Dr. Daena Sarah Watcha, MD, MS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Mary Sun, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Dept Of Emergency Medicine, Torrance, CA 90505 Phone: 310-717-6381 | |
Robert L.r. Gibbs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24325 Crenshaw Blvd, # 283, Torrance, CA 90505 Phone: 424-777-6642 Fax: 877-223-4535 | |
Dr. Shannon M Stacy, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance Memorial Medical Center, Torrance, CA 90505 Phone: 310-325-9110 |